DPP4 Inhibitors in the Management of Hospitalized Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Glycaemic efficacy and safety of linagliptin for the management of non-cardiac surgery patients with type 2 diabetes in a real-world setting: Lina-Surg study

(2019) Luis M. Pérez-Belmonte et al.   ANNALS OF MEDICINE

Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes

(2019) Julio Rosenstock et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: A pilot randomized study

(2018) Maya Fayfman et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Safety and Efficacy of DPP4 Inhibitor and Basal Insulin in Type 2 Diabetes: An Updated Review and Challenging Clinical Scenarios

(2018) Fernando Gomez-Peralta et al.   Diabetes Therapy

15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2019

(2018)   DIABETES CARE

Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial

(2018) Priyathama Vellanki et al.   DIABETES OBESITY & METABOLISM

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

(2018) Julio Rosenstock et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial

(2017) Francisco J Pasquel et al.   Lancet Diabetes & Endocrinology

Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis

(2016) Bernard Zinman et al.   Canadian Journal of Diabetes

Mortality among hospitalized patients with hypoglycemia: insulin-related and non-insulin related

(2016) A. Akirov et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Add-On Treatment with Teneligliptin Ameliorates Glucose Fluctuations and Improves Glycemic Control Index in Japanese Patients with Type 2 Diabetes on Insulin Therapy

(2014) Seiichi Tanaka et al.   Diabetes Technology & Therapeutics

Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction

(2013) P.-H. Groop et al.   DIABETES CARE

Increased Glycemic Variability Is Independently Associated With Length of Stay and Mortality in Noncritically Ill Hospitalized Patients

(2013) C. E. Mendez et al.   DIABETES CARE

Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?: Insulin therapy has proven itself and is considered the mainstay of treatment

(2013) G. E. Umpierrez et al.   DIABETES CARE

Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes: A pilot, randomized, controlled study

(2013) G. E. Umpierrez et al.   DIABETES CARE

Inpatient Medical Errors Involving Glucose-Lowering Medications and Their Impact on Patients: Review of 2,598 Incidents from A Voluntary Electronic Error-Reporting Database

(2013) Renee Amori et al.   Endocrine Practice

Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme

(2012) Odd Johansen et al.   Cardiovascular Diabetology

Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)

(2011) G. E. Umpierrez et al.   DIABETES CARE

Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4)

(2009) Nancy A. Thornberry et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE